Evidence map›Paper›PMID 33113000›Full record

Observational studyRheumatology international2021

Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage.

Burak Ince, Selay Artan, Yasemin Yalcinkaya, Bahar Artim-Esen, Ahmet Gul, Lale Ocal, Murat Inanc

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Burak InceDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey.ORCID http://orcid.org/0000-0001-9813-2228
Selay ArtanDepartment of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-3465-9252
Yasemin YalcinkayaDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey.ORCID http://orcid.org/0000-0001-9357-0456
Bahar Artim-EsenDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5659-3955
Ahmet GulDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey.ORCID http://orcid.org/0000-0001-8219-3720
Lale OcalDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey.ORCID http://orcid.org/0000-0003-3615-256X
Murat InancDivision of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Ozal Millet Cd, 34093, Fatih / Istanbul, Turkey. drinanc@istanbul.edu.tr.ORCID http://orcid.org/0000-0002-6376-5583
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study is to investigate the clinical characteristics and long-term prognosis including flares and organ damage in patients with giant cell arteritis (GCA) from a tertiary referral centre and compare these features in different subgroups. In this retrospective observational study, patients with GCA who were followed up in our vasculitis clinic between 1998 and 2018 were evaluated by a predefined protocol. Patients with and without cranial symptoms were compared for clinical and laboratory features, flares and permanent damage findings. Vasculitis Damage Index and Large Vessel Vasculitis Index of Damage were used for damage assessment. Records of 89 patients (median follow-up time 46 months) were analysed; mean time to diagnosis after initial symptom was longer in patients with acute vision loss (11 ± 4 vs. 4.8 ± 1.1 months p = 0.002). EGG (n = 19) was younger (63 ± 2 vs. 69 ± 1 years old p = 0.01); had higher mean CRP (141.8 ± 107.3 vs. 76.6 ± 67.9 mg/dL p = 0.023) and ESR (120.8 ± 25.1 vs. 99.3 ± 24.3 mm/h p = 0.004) at diagnosis. PET-CT detected large vessel vasculitis in 42/48 (87.5%) cases of the entire cohort. Thirty-one patients had flares and proportion of flared patients was significantly higher in patients with cranial symptoms. At least one damage item (DI) was present in 54 (60.7%) patients. The development of damage was found to be associated with flares. Evaluation of our cohort revealed the importance of early diagnosis for prevention of vision loss in GCA. Patients without cranial symptoms were younger, present with higher inflammatory response and for these, PET-CT was the main diagnostic tool. Relapse rate was higher in patients with cranial symptoms. Flares and accompanying corticosteroid treatment may contribute to organ damage in GCA.

Indexed as

AdultAgedAged, 80 and overDisease ProgressionFemaleFollow-Up StudiesGiant Cell ArteritisHumansMaleMiddle AgedPositron Emission Tomography Computed TomographyRecurrenceRetrospective StudiesVision DisordersGiant cell arteritisGlucocorticoidsPolymyalgia rheumaticaPositron emission tomographyReduced visionSymptom flare-up

Identifiers

PMID33113000
OpenAlexW3097838966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.